Sight Sciences Announces the Appointment of Tamara
MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative...
Stay updated with breaking news from Sight Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative...
Joe Manchin has long been a top recipient of campaign contributions from the energy sector, and last quarter’s data shows that trend has continued.
Cataract surgery is one of the most commonly performed procedures worldwide. Technological advances for preoperative assessment, IOL power calculation and surgical precision have increased safety and predictability, and the market offers a wide range of IOL options to satisfy patients’ needs. Nevertheless, unforeseen complications may occur, and some patients may be dissatisfied with their
Sight Sciences is seeing rapid revenue growth and over half of its market cap is net cash. Why am I still not enthusiastic about SGHT stock? Find out.
Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 216 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Sight Sciences to similar companies based on the strength of its earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and risk. Valuation and […]